Appendix 4D & Half Year Report 31 December 2025
Filed with ASX · · 24 pages · English
An explanation of the key financial elements contributing to the revenue and result above can be found in the review of operations included within the directors' report. Distributions No dividends have been paid during the financial half year. The directors do not recommend that a dividend be paid in respect of the financial half year (31 December 2024: Nil). Changes in controlled entity N/A Other
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Company Update
- Quarterly Activities/Appendix 4C Cash Flow Report
- Anatara receives firm commitments for $1.2m Placement
- Trading Halt
- Response to ASX Price Query
Later from Anatara Lifesciences
All Anatara Lifesciences news releasesFollow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences